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Abstract
Background: Hepatitis E virus (HEV) is a major public health problem in developing countries. HEV infection in 
pregnant women is more common and more often fatal in the third trimester. The mortality rate due to HEV-induced 
hepatitis is as high as 15-20 per cent. The present study was designed to determine the potential factors responsible for 
high mortality rate among pregnant women.
Findings: Twenty one pregnant women attended the Maternity Center of Begoua in the Central African Republic 
during an outbreak of hepatitis E virus between July and October 2002 with symptoms of acute liver disease. Their 
mean gestational period was 29.9 (SD 8.3 weeks) and they were aged from 15 to 39 years old. The serology IgM showed 
that seven women (33%) had acute hepatitis E. Among them, one woman, aged 35 and her newborn died after an 
apparently normal preterm delivery. The 6 remaining young women, age 18 - 22, had preterm deliveries which 
included three live babies and three stillborn with one macerated.
Conclusions: These results suggest that maternal age, in addition to hormonal, immunological and environmental 
factors, may be a risk factor for fatal outcome.
Findings
Hepatitis E virus (HEV) infection, a common cause of
water-borne epidemics, is endemic and frequently
responsible for acute viral hepatitis in developing coun-
tries. On the contrary, in the industrialized world, anti-
HEV antibodies are detected in the general population [1]
with no significant morbidity. Transmission is usually
feco-oral, although person-to-person transmission has
also been reported. Usually, an acute HEV infection is
self-limiting, shows no evidence of chronic HEV infection
in humans, and has a case-fatality rate of less than 0.1%.
However, this disease is responsible for high maternal
mortality during the third trimester of pregnancy in India
while reports from Egypt, Europe and the USA have
shown that the course and severity of HEV during preg-
nancy is no different from that observed in non-pregnant
women [2]. No clinical case was reported in the Central
African Republic until 2001 although hepatitis E (IgG)
antibodies have been regularly detected in the healthy
population [3]. The first epidemic cases of HEV in the
Central African Republic were reported in 2002 [4] and,
since then sporadic epidemic outbreaks of hepatitis E
were observed. Currently in the Central African Republic,
pregnant women are not routinely screened for HEV
antibodies. Here, we report on cases of pregnant women
who had been infected by hepatitis E in Bégoua, in the
Central African Republic, in 2002. The aim of this report
is to bring to the attention of health authorities the dam-
age caused by the hepatitis E virus among pregnant
women in the Central African Republic.
From July to October 2002, during an outbreak of viral
hepatitis E, 21 pregnant women received prenatal care at
the Maternity Center of Bégoua. The age of the patients
ranged from 15 to 39 years (mean ± SD is 23.5 ± 6.3). The
mean duration of gestation at admission was 29.9 ± 8.3
weeks. Two of the patients were in the first trimester,
seven (7) in the second and the twelve (12) remaining in
the third trimester.
The study received the ethical approval of the Scientific
Committee of the Faculty of Medicine of the University of
Bangui. All the patients were evaluated on the basis of
history, clinical examination and liver function profile.
They had no history of blood exposure or drug consump-
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Table 1: Obstetrical, biochemical and serological data of Central African Pregnant Women with acute viral hepatitis E
Patient 
Order
Age (years) Gestational 
Number
Parity ALAT (IU) HEV IgM HEV IgG Gestational 
age
(in week)
Delivery
(baby status)
Weight at 
birth in gram
Mother 
status
1 21 III I 2200 Pos - 33 Premature (Macerated 
Stillborn)
2350 Survived
2 19 II I 1420 Pos - 28 Premature (alive) 1970 Survived
3 22 IV II 1130 Pos - 37 Premature (alive) 2630 Survived
4 35 VI V 1030 Pos - 32 Premature (Died few 
min later)
1400 Died
5 20 I 0 1260 Pos - 31 Premature (alive) 1600 Survived
6 20 VI III 980 Pos - 28 Premature (Stillborn) NA* Survived
7 18 II I 1380 Pos - 28 Premature (Stillborn) NA Survived
8 30 I 0 704 Neg Pos 22 Premature (Stillborn) 1000 Survived
9 35 IX VIII 940 Neg Pos 22 Miscarriage 400 Survived
10 17 II I 700 Neg Pos 40 term (alive) NA Survived
11 26 IV III 973 Neg Pos 28 Premature (alive) 1910 Survived
12 33 VIII VI 3560 Neg Pos 19 Miscarriage NA Survived
13 19 I 0 950 Neg Pos 28 Premature (alive) NA Survived
14 22 I 0 1130 Neg Pos 39 term (alive) NA Survived
15 24 IV III 1004 Neg Pos 36 Premature (alive) 1850 Survived
16 16 I 0 225 Neg Pos 32 Premature (alive) 1900 Survived
17 30 III II 110 Neg Neg 32 Premature (alive) NA Survived
18 18 I 0 340 Neg Neg 41 term (alive) NA Survived
19 20 II I 135 Neg Pos 32 Premature (alive) NA Survived
20 20 I 0 632 Neg Neg 40 term (alive) NA Survived
21 15 I 0 820 Neg Pos 40 term (alive) 2300 Survived
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tion. Initial symptoms included jaundice, fever, anorexia,
asthenia, hepatomegaly and gastrointestinal pain. Biolog-
ical tests were conducted on sera obtained from all
patients. The levels of alanine aminotransferase were
over 10 times the norm. Yellow fever and malaria tests
were negative. As it was epidemic in the area at this time,
acute hepatitis E was suspected but only confirmed for
seven (7) women (33.3%) by ELISA (anti-HEV antibody
IgM, Biokit (Sensitivity and specificity at 100%), Spain).
Serology for hepatitis B and C could not be performed.
Among the fourteen remaining pregnant women, eleven
presented anti-HEV antibodies (IgG) showing previous
contact with HEV which could not be dated. Only three
pregnant women had negative HEV serology and deliv-
ered healthy babies: two at term and one at 8 months.
All seven (7) women infected by hepatitis E virus had
preterm delivery. Among them three had live babies and
three stillborn including one macerated. In the final case,
patient 4 (Table 1) was admitted to the Maternity Center
of Begoua with a normal temperature and low blood-
pressure (90/60 mm Hg). Two days later, she was evacu-
ated to the referral hospital for metrorrhagia. She was
delivered of a premature child, who died a few minutes
after birth. The mother died 5 hours later of postpartum
hemorrhage (Prothrombin time was 31 seconds with the
control at 12.2 seconds showing that prothrombin ratio
was under 15% and hemoglobin level was at 6 g/L).
Although not significant, this outcome differed from the
fourteen (14) other women as did the six (6) such out-
comes which were observed (Table 1). Several studies
have shown that the incidence of HEV infection in preg-
nancy is high and a significant proportion of pregnant
women can progress to fulminant hepatitis, with a high
mortality rate during their third trimester [5-7]. In Sudan,
a fatality rate of 17.8% was found during an outbreak in
Darfur, with a rate of 31.1% among pregnant women [8].
The mechanism of severe liver injury in pregnant women
with hepatitis E mortality remains a mystery [1]. Never-
theless, new insights into the pathophysiology of the
interaction of hepatitis E and pregnancy suggest the
involvement of immunology and host susceptibility fac-
tors and their interaction plays a role in disease processes
[2].
Our study shows that the differences between these
seven women consisted of their gestational number, their
parity and their age. Only the 35 year old died five hours
after she delivered her baby. All the other pregnant
women infected were much younger (18 - 21 years old)
even though some had the same gestational number as
that of the deceased. This leads to the conclusion that the
age of the patient might be another factor, in addition to
hormonal and immunological factors, in the mechanism
leading to mortality of the pregnant women in their third
trimester. Our study is limited by the fact that only seven
pregnant women presented acute hepatitis E and only
one of them died.
Although several studies have been carried out on the
factors that could be involved in the mortality of pregnant
women infected by hepatitis E in their third trimester, few
were related to the interactions of age/hormonal factors,
age/immunological factors and age/environmental fac-
tors. It would be interesting to explore this avenue in
order to decipher the influence of age on the fatal evolu-
tion of this disease among pregnant women.
Since vertical transmission risk was reported for hepa-
titis E virus [9] the death of the newborn and also the
stillborn babies were likely due to the mother-child trans-
mission by the mother who presented an acute hepatitis
either during the delivery or during the third trimester of
pregnancy [10-12]. It will also be interesting to explore
this avenue in order to find better mechanisms for pre-
venting this transmission.
In addition to the observation that a decrease in cellular
immunity during pregnancy, coupled with high levels of
steroid hormones, may influence hepatitis E viral replica-
tion to cause the reported high mortality [13], age may
also be a risk factor that may have played a role in the
fatal case observed. The mortality rate of hepatitis E is
elevated in adults and the conjunction of age, multiparity
and pregnancy should be further investigated to confirm
this observation. Screening and follow up studies of preg-
nant women and their newborns for HEV infection are
thus important for improving knowledge about the epi-
demiology (transmission and circulation) and transmis-
sion pathway of this virus. More extensive studies should
be conducted to characterize the circulating HEV geno-
types and to determine the current pathological and risk
status in the general population as a whole and in preg-
nant women in particular in the Central African Repub-
lic.
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